Table 2. Healthcare Resource Utilization.
| Age Group | ||||
| Patients With Newly Diagnosed HIV-1 | Patients Initiated With PrEP | |||
| 10-17 y | 18-64 y | 10-17 y | 18-64 y | |
| Total No. of patients | 220 | 18 154 | 175 | 34 123 |
| Length of follow-upa (mo), mean (SD) | 20.9 (15.7) | 17.8 (15.1) | 18.4 (14.6) | 16.8 (14.1) |
| All-cause healthcare resource utilization | ||||
| Patients with ≥1 admission/visit, n (%) | ||||
| Inpatient hospitalization | 27 (12.3) | 4106 (22.6) | 44 (25.1) | 2324 (6.8) |
| ED visit | 74 (33.6) | 5386 (29.7) | 73 (41.7) | 6072 (17.8) |
| Office visit | 206 (93.6) | 17 028 (93.8) | 156 (89.1) | 29 413 (86.2) |
| Outpatient encounterb | 215 (97.7) | 17 707 (97.5) | 157 (89.7) | 30 331 (88.9) |
| Pharmacy prescriptions | 173 (78.6) | 16 030 (88.3) | 175 (100.0) | 34 118 (100.0) |
| No. of admissions/visits PPPM, mean (SD) | ||||
| Inpatient hospitalization | 0.01 (0.06) | 0.02 (0.09) | 0.03 (0.07) | 0.01 (0.05) |
| ED visit | 0.04 (0.07) | 0.04 (0.08) | 0.07 (0.10) | 0.02 (0.06) |
| Office visit | 0.40 (0.35) | 0.62 (0.60) | 0.60 (0.57) | 0.52 (0.49) |
| Outpatient encounterb | 2.29 (2.61) | 4.37 (6.18) | 2.53 (2.12) | 3.09 (3.12) |
| Pharmacy prescriptions | 0.65 (0.90) | 1.71 (1.91) | 1.47 (1.50) | 1.68 (1.57) |
| HIV-related healthcare resource utilization | ||||
| Patients with ≥1 admission/visit, n (%) | ||||
| Inpatient hospitalization | 11 (5.0) | 1774 (9.8) | NA | NA |
| ED visit | 21 (9.5) | 1855 (10.2) | NA | NA |
| Office visit | 75 (34.1) | 9159 (50.5) | NA | NA |
| Outpatient encounterb | 185 (84.1) | 15 817 (87.1) | NA | NA |
| Pharmacy prescriptions | 34 (15.5) | 6708 (37.0) | NA | NA |
| No. of admissions/visits PPPM, mean (SD) | ||||
| Inpatient hospitalization | 0.004 (0.02) | 0.01 (0.06) | NA | NA |
| ED visit | 0.01 (0.03) | 0.01 (0.04) | NA | NA |
| Office visit | 0.06 (0.15) | 0.15 (0.26) | NA | NA |
| Outpatient encounterb | 0.65 (1.32) | 1.29 (2.26) | NA | NA |
| Pharmacy prescriptions | 0.14 (0.38) | 0.34 (0.51) | NA | NA |
Abbreviations: ED, emergency department; NA, not applicable; PPPM, per patient per month; PrEP, pre-exposure prophylaxis.
aNewly diagnosed HIV-1 patients were followed from the diagnosis index date to the earlier of end of continuous enrollment in the database or end of study period. Patients initiated with PrEP were followed from the treatment index date to the earliest of HIV-1 diagnosis, end of continuous enrollment, or end of the study period.
bIncludes laboratory testing.